Brief: Vita Life Sciences Says Expects FY2022 Pre-Tax Profit Of A$9.5-10.0 Mln
28/11/2022 06:04
Nov 28 (Reuters) - Vita Life Sciences Ltd VLS.AX :
* SEES FY2022 PRE-TAX PROFIT OF A$9.5-10.0M
* SEES SALES OF A$64.0 MILLION-A$65.0 MILLION FOR FY22
* MARKET CONDITIONS ACROSS COMPLEMENTARY MEDICINE CATEGORIES
CONTINUE TO REMAIN STRONG
* SOFTER TRADING CONDITIONS ARE EXPECTED IN 1H2023 ACROSS
COMPLEMENTARY MEDICINE CATEGORIES
Source text for Eikon: ID:nASX5T18GB
Further company coverage: VLS.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vita Life Sciences
See all newsBrief: Vita Life Sciences Guides H1 Sales At A$46.3 Million-A$47.3 Million
Brief: Vita Life Sciences Sees Pre-Tax Profit A$6.2M-A$6.7M For Half Year
Australia's Vita Life Sciences slips on subdued earnings forecast
Brief: Vita Life Sciences Sees Half Year Sales Of A$39.0M-A$40.0M
Brief: Vita Life Sciences Delays Date To Hold AGM To 22 May